Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Medela Potentia Tbk. (MDLA) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Medela Potentia Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Medela Potentia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Medela Potentia Tbk. trades at Rp210 (market cap 2.97T, 772.4K 24h volume). The key difference: Medela Potentia Tbk. is far larger — about 9.4× Diagnos Laboratorium Utama Tbk.'s market cap, and Medela Potentia Tbk. is more actively traded (772.4K versus 41.7K). Which is the better fit depends on your goals.

DGNSMDLA
Market Cap
316.25B2.97T
Volume
41.7K772.4K
Lot
4177.72K
Turnover
9.66M161.92M
Average Price
231.65209.64
Value
9.66M161.92M
Indicative Equilibrium Price
230210
Indicative Equilibrium Volume
2.4K2

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
MDLA
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Medela Potentia Tbk.

PT Medela Potentia Tbk. (Company) was established based on Deed of Establishment No. 04 dated August 5, 2011, of Public Notary Evy Ferdiana, S.H, Notary of Bekasi Regency, domiciled in Lemah Abang. The Company started its operation activities in 2013.

Read more on MDLA